Chronic Lung Disease of Prematurity Completed Phase 3 Trials for Nitric Oxide (DB00435)

Also known as: Bronchopulmonary Dysplasia / Dysplasia, Bronchopulmonary / Ventilator lung in newborn / Congenital pulmonary fibrosis

IndicationStatusPhase
DBCOND0044076 (Chronic Lung Disease of Prematurity)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00931632Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm InfantsTreatment